Software Leads the CANSLIM Screener with 49 of 127 Names

CANSLIM stock screener, 22 October 2026: 127 stocks, 3 passed all three screens; largest group Software with 49 names.

CANSLIM Stock Screener · · 127 stocks

Software Leads the CANSLIM Screener with 49 of 127 Names

The CANSLIM stock screener flagged 127 stocks on 22 October, 18 more than the previous trading day (109), with 18 new entries and 0 drops. Only 3 passed all three screens and 17 passed two; the remaining 107 passed one.

By group, Software 49 names (39%); Oil & Gas Midstream 10 names (8%); Oil & Gas Integrated 7 names (6%). Software accounts for 7 of the 18 new entries, the largest cluster among the day's additions.

The 3 names confirmed by every screen (GCT, NTAP, ZBRA) span 2 industry groups. RS Rating is available for 28 of the 127 names; 28 of those score 90 or above.

For educational purposes only — not investment advice.

Last updated: 22 October 2026, 05:30 (UTC+8)

How We Scan: The Criteria behind This List

A stock enters the list when it passes at least one of three independent screens. The Screens column shows how many it passed; within each industry group, stocks that passed more screens are listed first. Rules are fixed and applied mechanically every trading day, with no discretionary picks.

Screen 1 · Relative-Strength Leaders

Every condition in group A, plus at least one condition in group B.

  • A. Industry group: Semiconductors & Semiconductor Equipment; Software & Services; Technology Hardware & Equipment; or Consumer Discretionary Distribution & Retail
  • A. Share price above $20
  • A. Average daily trading value (20 days) above $20 million
  • A. Stage 2 uptrend (Weinstein stage analysis)
  • B. Momentum-strength score above 85 over 1 month, or above 85 over 3 months, or above 95 over 1 week

Screen 2 · Growth near New Highs

  • Share price above $10; 50-day average volume above 100,000 shares
  • Latest-quarter earnings growth above 20% and sales growth above 20%
  • Earnings-strength score above 75; 6-month relative-strength score above 80
  • Accumulation/distribution grade of B or better
  • Price within 15% of its 52-week high

Screen 3 · Quality Growth Leaders

  • Composite score, earnings score and relative-strength score each between 80 and 99
  • Industry-group strength grade A, B or C
  • Sales, margin and return-on-equity grade A, B or C
  • Accumulation/distribution grade A, B or C

Screen 3 results in this list were last refreshed on 21 October 2026; that screen is updated less often than Screens 1 and 2. The list is a set of candidates for study, not a recommendation to buy or sell any security. Technical readings (trend, pattern, base depth) are mechanical approximations and should be checked by eye.

Frequently Asked Questions

How Many Stocks Passed the CANSLIM Screens on 22 October?

127 stocks passed at least one of the three screens. 3 passed all three and 17 passed two.

Which Industry Group Has the Most Stocks Today?

Software has the most, with 49 of 127 names (39%), followed by Oil & Gas Midstream (10) and Oil & Gas Integrated (7).

What Does CANSLIM Stand for?

CANSLIM is O'Neil's stock-selection method: Current quarterly earnings, Annual earnings growth, New products, management or price highs, Supply and demand, Leader or laggard, Institutional sponsorship, and Market direction.

How often Is the List Updated?

Once each trading day. The rules are fixed and applied mechanically, with no discretionary picks.

Is This List Investment Advice?

No. It is a set of candidates for study, published for educational purposes only. It is not a recommendation to buy or sell any security.

See the latest CANSLIM stock screener · Previous trading day.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.